TAO SHEN to Carcinoma, Basal Cell
This is a "connection" page, showing publications TAO SHEN has written about Carcinoma, Basal Cell.
Connection Strength
0.219
-
Screening and identification of versican as a sensitive biomarker and potential therapeutic target in basal cell carcinoma. Int J Med Sci. 2025; 22(10):2488-2501.
Score: 0.219